These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6639274)

  • 1. [A Copernican revolution in neuropathology. Implications of the discovery of lesions in the nucleus basalis in Alzheimer's disease].
    Muñoz García D
    Arch Neurobiol (Madr); 1983; 46(3):159-60. PubMed ID: 6639274
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I; Hirano A
    Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
    Whitehouse PJ; Price DL; Clark AW; Coyle JT; DeLong MR
    Ann Neurol; 1981 Aug; 10(2):122-6. PubMed ID: 7283399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Gauthier S; Nair NP
    Can J Physiol Pharmacol; 1986 Mar; 64(3):318-24. PubMed ID: 3708439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease.
    Allen SJ; Dawbarn D; Wilcock GK
    Brain Res; 1988 Jun; 454(1-2):275-81. PubMed ID: 3409011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
    Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic and molecular neuropathology of Alzheimer's disease].
    Duyckaerts C; Panchal M; Delatour B; Potier MC
    Ann Pharm Fr; 2009 Mar; 67(2):127-35. PubMed ID: 19298896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autopsy case of atypical type of alzheimer's disease clinically diagnosed as corticobasal degeneration].
    Osako M; Mochizuki Y; Kugio Y; Mizutani T; Hayashi H
    Rinsho Shinkeigaku; 2007 Sep; 47(9):581-4. PubMed ID: 18018616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of Parkinsonism in Alzheimer's disease.
    Kovari E; Bouras C; Herrmann FR; Burkhard PR; Horvath J; Xekardaki A
    Adv Exp Med Biol; 2015; 822():149. PubMed ID: 25416984
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
    J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropathology of Alzheimer's disease].
    Hauw JJ; Escourolle F; Colle MA; Duyckaerts C
    Ann Pathol; 2000 Oct; 20(5):448-57. PubMed ID: 11084412
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological characteristic of Alzheimer's disease produced by lesion in nucleus basalis of Meynert in rats.
    Li L; An X; Qiao J
    Chin Med J (Engl); 1998 Jul; 111(7):638-40. PubMed ID: 11245053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal loss in Alzheimer's disease.
    Hyman BT
    Aging (Milano); 1998 Apr; 10(2):156. PubMed ID: 9666209
    [No Abstract]   [Full Text] [Related]  

  • 20. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.